Announcing the newly named Prime Therapeutics Report, focused on complex and chronic disease management trends - Prime Therapeutics
Announcing the newly named Prime Therapeutics Report, focused on complex and chronic disease management trends
Fall 2024 edition provides insights into groundbreaking specialty solutions for managed care
Prime Therapeutics (Prime) today launched its 2024 fall Prime Therapeutics Report (formerly Magellan Rx Report). Focused on innovations in the oncology space, Prime celebrates this 41st edition of its managed care report with a new name and design and the same in-depth industry articles on trending specialty topics the report’s followers have come to expect. The triannual report gives an in-depth analysis of trends associated with high-cost, innovative therapies and the latest updates to inform Prime clients’ coverage and benefit decisions.
This edition’s cover story explores changes, challenges and management strategies in chimeric antigen receptor (CAR) T-cell therapy in the oncology space.
The Prime Therapeutics Report fall edition also includes expert commentary on the following topics:
- Advanced melanoma: First approved cell therapy and payer considerations for appropriate treatment.
- Non-small cell lung cancer: More targeted treatment approvals and payer impact.
- Oncology accelerated approval update: Traditional approvals and withdrawals.
- Acute myeloid leukemia: New approval for patients with specific gene mutation.
- Oncology site of service: Updates in U.S. Food and Drug Administration clinical trial guidelines and potential implications.
Download a copy of the report to go deeper into these timely trends.
Follow ways Prime is leading the industry in specialty care management solutions.
To stay on top of managed care trends and become a Prime Therapeutics Report subscriber, email PTReport@PrimeTherapeutics.com.
About Prime Therapeutics
Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization. We offer innovative pharmacy benefit management, specialty and medical drug management, and state government solutions to millions of people across the country. At Prime, we’re reimagining pharmacy solutions to provide the care we’d want for our loved ones. We challenge the way it’s always been done to develop intelligently designed solutions that deliver savings, simplicity and support to help people achieve better health. For more information, visit us at PrimeTherapeutics.com or follow us on LinkedIn.